国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Fallopia japonica: Bioactive Secondary Metabolites and Molecular Mode of Anticancer

Mahmoud Zaki El-Readi, Safaa Yehia Eid, Hiba Saeed Al-Amodi1 and Michael Wink

Traditional medicinal plants are a large source of natural anticancer compounds that might serve as leads for the development of novel drugs. In recent years, the scientific community in the Western world has recognized the potential of natural products, used in Traditional Chinese Medicine (TCM). Since ancient times Japanese knotweed (Fallopia japonica), has been utilized in many TCM herbal preparations as anti-cancer agent. F. japonica (FJ) is known to produce a series of bioactive secondary metabolites, including anthraquinones, stilbens, tannins, lignans, anthocyanins, phenethyl alcohols, sterols, and essential oils. Resveratrol (a stilben) and emodin (an anthraquinone) are the major active ingredients of FJ. The anticancer activity of both compounds has various molecular modes of action and mechanisms through their ability to modulate the proliferation, apoptosis, cell cycle, growth factors, protein kinase C (PKC), NF-kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) signaling cascades. This review presents an overview of the secondary metabolites of F. japonica and anticancer activities of the extract and main active principles, resveratrol and emodin. The possible molecular targets and potential chemopreventive effects are discussed.